文献速递心律失常

房颤风险的性别差异:VITAL Rhythm研究

Sex Differences in Atrial Fibrillation Risk: The VITAL Rhythm Study.
PubMed 文献 · JAMA Cardiol · 2022-01-01

校正年龄和治疗分组后,女性房颤风险低于男性(HR 0.68),但进一步校正身高或体表面积后,女性风险反而高于男性。

要点

  • 女性房颤风险低于男性,但该保护作用主要由体型差异解释。
  • 校正身高或体表面积后,女性房颤风险高于男性。
  • 房颤风险因素与房颤的关联在男女间相似。

核心结论

  • 在无基线心血管疾病的人群中,校正身高和/或体型后,女性房颤风险高于男性,提示体型差异解释了大部分女性性别与房颤的保护性关联。

主要发现

  • 中位随访5.3年,男性房颤事件495例(4.0%),女性405例(3.2%)。
  • 校正年龄和治疗分组后,女性房颤风险低于男性(HR 0.68;95%CI 0.59-0.77;P<.001)。
  • 进一步校正种族、吸烟、饮酒、高血压、糖尿病、甲状腺疾病、运动和BMI后,女性房颤风险仍较低(HR 0.73;95%CI 0.63-0.85;P<.001)。
  • 以身高替代BMI校正后,女性房颤风险高于男性(HR 1.39;95%CI 1.14-1.72;P=.001)。
  • 以身高和体重替代BMI校正后(HR 1.49;95%CI 1.21-1.82;P<.001),或以体表面积替代BMI校正后(HR 1.25;95%CI 1.06-1.49;P=.009),女性房颤风险均高于男性。

临床怎么用

  • 评估女性房颤风险时应考虑身高和体型,而非仅用BMI。
  • 女性房颤预防策略需重视,尤其体型较大者可能风险更高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Women have a lower incidence of atrial fibrillation (AF) compared with men in several studies, but it is unclear whether this sex difference is independent of sex differences in prevalent cardiovascular disease (CVD), body size, and other risk factors. OBJECTIVE: To examine sex differences in AF incidence and whether AF risk factors differ by sex in a contemporary cohort of men and women without prevalent CVD. DESIGN, SETTING, AND PARTICIPANTS: This was a prospective cohort analysis within the Vitamin D and Omega-3 Trial (VITAL) Rhythm Study, a randomized trial that examined the effect of vitamin D and ω-3 fatty acid supplementation on incident AF among men 50 years or older and women 55 years or older without a prior history of prevalent AF, CVD, or cancer at baseline. Data were analyzed from September 29, 2020, to June 29, 2021. EXPOSURES: Sex, height, weight, body mass index (BMI), body surface area (BSA), and other AF risk factors at study enrollment. MAIN OUTCOMES AND MEASURES: Incident AF confirmed by medical record review. RESULTS: A total of 25 119 individuals (mean [SD] age, 67.0 [7.1] years; 12 757 women [51%]) were included in this study. Over a median (IQR) follow-up of 5.3 (5.1-5.7) years, 900 confirmed incident AF events occurred among 12 362 men (495 events, 4.0%) and 12 757 women (405 events, 3.2%). After adjustment for age and treatment assignment, women were at lower risk for incident AF than men (hazard ratio [HR], 0.68; 95% CI, 0.59-0.77; P < .001). The inverse association between female sex and AF persisted after adjustment for race and ethnicity, smoking, alcohol intake, hypertension, diabetes (type 1, type 2, gestational), thyroid disease, exercise, and BMI (HR, 0.73; 95% CI, 0.63-0.85; P <.001). However, female sex was positively associated with AF when height (HR, 1.39; 95% CI, 1.14-1.72; P = .001), height and weight (HR 1.49, 95% CI, 1.21-1.82; P <.001), or BSA (HR, 1.25; 95% CI, 1.06-1.49; P = .009) were substituted for BMI in the multivariate model. In stratified models, risk factor associations with incident AF were similar for women and men. CONCLUSIONS AND RELEVANCE: In this cohort study, findings suggest that after controlling for height and/or body size, women without CVD at baseline were at higher risk for AF than men, suggesting that sex differences in body size account for much of the protective association between female sex and AF. These data underscore the importance of AF prevention in women.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Siddiqi HK, Vinayagamoorthy M, Gencer B, et al. Sex Differences in Atrial Fibrillation Risk: The VITAL Rhythm Study. JAMA Cardiol. 2022. PMID: 36044209. doi:10.1001/jamacardio.2022.2825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。